tiprankstipranks
Trending News
More News >
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Belite Bio, Inc. ADR (BLTE) Similar Stocks

Compare
34 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Belite Bio, Inc. ADR
$59.90
$1.99B
29.25%
5 Buy
0 Hold
0 Sell
Strong Buy
Denali Therapeutics
$14.10
$2.10B
-39.28%
12 Buy
0 Hold
0 Sell
Strong Buy
Beam Therapeutics
$16.80
$1.69B
-32.37%
13 Buy
2 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$40.33
$1.69B
59.74%
5 Buy
0 Hold
0 Sell
Strong Buy
NewAmsterdam Pharma Company
$18.45
$2.06B
-5.59%
11 Buy
0 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$5.40
$2.04B
-42.58%
1 Buy
4 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BLTE
Belite Bio, Inc. ADR
59.04
13.36
29.25%
DNLI
Denali Therapeutics
14.10
-9.12
-39.28%
BEAM
Beam Therapeutics
16.80
-6.63
-28.30%
TARS
Tarsus Pharmaceuticals
40.35
13.17
48.45%
NAMS
NewAmsterdam Pharma Company
18.57
-0.64
-3.33%
RXRX
Recursion Pharmaceuticals
5.03
-2.47
-32.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis